A Study Of Quai.MD AI-based Platform For Chest Pain Related Pathways

Overview

About this study

The purpose of this study is to demonstrate the value of the Quai platform in implementing pathways, we propose the following primary objectives for this pilot:

Demonstrate that implementation of the Quai.MD platform improves chest pain/shortness of breath (ACS/PE) clinical pathways adherence in the emergency department
Demonstrate the usability of the Quai.MD application and its smooth integration into the providers’ workflow in Epic
Demonstrate that implementing pathways using the Quai platform brings direct economic value to the ED
To gain a wide-spectrum view on implementation at the providers’ workspace to learn about the interplay of pathway use and clinical workflow.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Providers caring for patients who present to the Emergency Department at St. Marys with signs or symptoms suggestive of Acute coronary Syndrome (ACS) or PE, and patients who present with a chief complaint of chest pain or shortness of breath.

Exclusion Criteria:

Providers caring for patients who present to the Emergency Department at St. Marys with patients showing an ST segment elevation myocardial infarction (STEMI) or in cardiac arrest before or during their ED course.
Providers unable or unwilling to consent to participate in the Quai MD pathway project.
Patients who have declined research authorization.
Patients under the age of 18 at the time of ED presentation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 03/18/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Laura Walker, M.D., M.B.A.	Contact us for the latest status

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Laura Walker, M.D., M.B.A.

Contact us for the latest status

More information

Publications

Publications are currently not available

Clinical Trials